DVx (TSE:3079) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:3079 DVx Inc TSE:3079
64 GF Score
Price 円993.00
GF Value 円1,183.84
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is DVx Research & Development?

DVx TSE:3079 -0.10% 64 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:3079 with a GF Score™ of 64/100 and a GF Value™ of 円1,183.84 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DVx's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

DVx  (TSE:3079) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DVx Research & Development Related Terms

DVx Research & Development Historical Data

* Premium members only.

The historical data trend for DVx's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DVx Research & Development Chart

DVx Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DVx Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3079
64GF Score
DVx Inc TSE:3079
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DVx Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
DVx (TSE:3079) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on DVx and its competitors.
Is DVx's Research & Development too high?
DVx's current Research & Development is 円0 Mil. Overall, DVx has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DVx's Research & Development compare to ABT and SYK?
DVx's Research & Development of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DVx and its competitors. DVx's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DVx stock overvalued right now?
Based on GuruFocus' analysis, DVx (TSE:3079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,183.84, compared to a current price of 円993.00 — trading 16.1% below its estimated fair value. The current Research & Development is 円0 Mil. DVx's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DVx (TSE:3079), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DVx (TSE:3079) Overvalued in 2026?

Based on GuruFocus' analysis, DVx stock appears to be undervalued. The current stock price of 円993.00 is trading 16.1% below its estimated GF Value™ of 円1,183.84. GuruFocus considers DVx to be Modestly Undervalued.

Key valuation signals for TSE:3079:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,183.84 vs. price of 円993.00 (16.1% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the TSE:3079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DVx Business Description

Address Mejiro Nakano Building, 5th Floor, 2-17-22 Takada, Toshima-ku, Tokyo, JPN, 171-0033
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.
64GF Score

Get the complete analysis for TSE:3079

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円993.00
Price
円1,183.84
GF Value